WASHINGTON, March 19 -- Sen. Josh Hawley issued the following press release:
Today, U.S. Senator Josh Hawley (R-Mo.) sent letters to two chemical abortion drug manufacturers-Danco Laboratories and GenBioPro- to inform them that he is opening an investigation into their business practices related to mifepristone as mounting evidence shows women are suffering alarming rates of adverse-effects after taking the drug.
"I write to inform you that I am opening an investigation into Danco Laboratories and its manufacture, distribution, and marketing practices relating to mifepristone. Mounting evidence suggests that mifepristone poses grave risks to women. Yet your company has continued to profit from the widespread distribution of this drug even...